Archives
-
Entinostat: From HDAC Signal to Translation
2026-09-12
Entinostat (MS-275, SNDX-275) offers translational researchers a selective way to interrogate class I HDAC biology, but its value depends on distinguishing growth arrest from true cell killing. This article connects mechanism, assay design, preclinical validation, and clinical strategy to build more decision-ready oncology studies.
-
Chlorpromazine HCl in Endocytosis Assay Design
2026-09-11
Chlorpromazine HCl is a dopamine receptor antagonist with value beyond conventional neuropharmacology studies. This article develops an evidence-bounded framework for using its receptor and synaptic actions alongside electrical-stimulation endocytosis assays without confusing pharmacological inhibition with nanoparticle uptake mechanisms.
-
Bifendate–Cyclosporine Interaction by CYP3A4 Genotype
2026-09-11
The reference study showed that bifendate lowers cyclosporine exposure and increases oral clearance in healthy subjects, with the largest effect in CYP3A4*18B/*18B carriers. Its randomized crossover design provides an early pharmacogenetic framework for evaluating DDB-associated drug interactions and for guiding therapeutic monitoring.
-
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301)
2026-09-10
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, peptides, antibodies, nucleic acids, and other targets from complex samples. They are well suited to purification, immunoprecipitation, and interaction workflows, but require validation when harsh elution, live-cell handling, or highly hydrophobic sample matrices are involved.
-
Podophyllotoxin: From Target to Assay
2026-09-10
Podophyllotoxin is a microtubule-directed research compound with powerful utility in cell-cycle, apoptosis, resistance, and autophagy studies. This article provides an evidence-aware framework for choosing orthogonal assays and separating parent-compound findings from derivative data.
-
5-Aminolevulinic acid HCl in Heme Research
2026-09-09
5-Aminolevulinic acid HCl enables controlled pathway perturbation, fluorescence-linked readouts, and mechanistic testing in heme and host–pathogen studies. This workflow connects Salmonella haem biology with practical macrophage phagocytosis assays while distinguishing validated evidence from exploratory applications in cancer research.
-
ROS-Responsive Nanoparticles and Cuproptosis
2026-09-09
Guo and colleagues developed ROS-responsive PHPM nanoparticles that co-deliver elesclomol and copper to induce cuproptosis in bladder cancer models. The study further shows that combining this nanomedicine with αPD-L1 can reshape the tumor microenvironment and improve antitumor immune responses, while transcriptomic analysis helps connect intracellular cell death with immunotherapy.
-
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit
2026-09-08
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables flexible fluorescent RNA probe synthesis for TREM2 macrophage research. This article connects Cy5-UTP incorporation with assay design, tissue localization, and the mechanistic findings of a recent cleavage-resistant TREM2 study.
-
ML385 and NRF2: A Ferroptosis-Aware Guide
2026-09-07
ML385 is a selective NRF2 inhibitor for dissecting redox adaptation, ferroptosis, and cancer therapeutic resistance. This guide uses recent pancreatic cancer findings to develop a phenotype-aware framework for interpreting NRF2 inhibition in non-small cell lung cancer research and combination studies.
-
Lactate-Driven HMGB1 Release in Polymicrobial Sepsis
2026-09-07
The reference study identifies lactate as an active regulator of macrophage HMGB1 release, linking lactylation, acetylation, exosome secretion, and endothelial barrier dysfunction in polymicrobial sepsis. Its genetic, cellular, and in vivo experiments support lactate-associated signaling as a mechanistic target, while also defining important limits for translation beyond the tested models.
-
Substance P: From NK-1 Biology to Assay Design
2026-09-05
Explore how Substance P connects tachykinin signaling with pain transmission research, inflammation, and immune response modulation. This evidence-calibrated guide explains how to separate receptor biology, peptide handling, and fluorescence-based analytical decisions.
-
CH 223191: AhR Antagonist Workflow
2026-09-05
CH 223191 enables controlled interrogation of AhR-dependent transcription in dioxin toxicity, intestinal regeneration, and microbiota–host signaling studies. This guide pairs practical dosing and assay design with troubleshooting strategies that distinguish pathway blockade from solvent effects or nonspecific cytotoxicity.
-
SAR405: A Precision Vps34 Inhibitor Workflow
2026-09-04
SAR405 enables selective interrogation of Vps34-dependent PtdIns3P production, autophagosome formation, and lysosome biology without broadly inhibiting class I or II PI3Ks. This workflow connects quantitative imaging with the emerging AMPK–ULK1 energy-stress model to improve autophagy inhibition, vesicle trafficking modulation, and cancer research assays.
-
5X Protein Loading Buffer (Reducing) Guide
2026-09-04
5X Protein Loading Buffer (Reducing), SKU K1164, prepares protein samples for denaturing and reducing SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and tracking dye. It is intended for molecular-weight-based separation under reducing conditions and should not be used when native structure, activity, or non-reducing disulfide patterns must be preserved.
-
Tigecycline Workflows for MDR Bacterial Research
2026-09-03
Tigecycline is a glycylcycline antibiotic that gives researchers a mechanistically distinct way to profile multidrug-resistant bacteria, validate MIC assays, and connect phenotype with plasmid transmission. This practical guide translates recent CREC epidemiology into reproducible susceptibility, time-kill, and resistance-surveillance workflows.